Revenue: The sum of all revenue fields included for a company's operating activities.
Atara Biotherapeutics, Inc. (ATRA) had Revenue of $0.63M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
|
Revenue |
$0.63M |
$-4.83M |
|
$0.19M |
|
$0.44M |
|
$5.35M |
|
$-4.72M |
|
$-0.11M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.83M |
|
$-4.72M |
|
$-4.74M |
|
15.03M |
|
15.03M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$13.53M |
|
$0.04M |
|
$7.49M |
|
$21.02M |
|
$6.85M |
|
-- |
|
$51.17M |
|
$58.02M |
|
$-37.00M |
|
$-37.00M |
|
$-37.00M |
|
9.44M |
|
| Cash Flow Statement Financials | |
$-6.41M |
|
$-6.63M |
|
$7.78M |
|
$8.48M |
|
$3.22M |
|
$-5.26M |
|
$1.14M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
69.68% |
|
-749.21% |
|
-749.21% |
|
-- |
|
-767.14% |
|
-767.30% |
|
$-6.41M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
1.98 |
|
45.43 |
|
13.07% |
|
13.07% |
|
-22.99% |
|
13.07% |
|
$-3.92 |
|
$-0.43 |
|
$-0.43 |
|